The Reproductive Years of Women with Perinatally Acquired HIV: From Gynecologic Care to Obstetric Outcomes

Infect Dis Clin North Am. 2019 Sep;33(3):817-833. doi: 10.1016/j.idc.2019.04.004. Epub 2019 Jun 24.

Abstract

Women with PHIV have distinct medical and social concerns in the context of lifelong immunosuppression, complex HIV care, and stigma because of with HIV from an early age. This article reviews the gynecologic and obstetric concerns experienced by women with PHIV. Cervical cancer screening is suboptimal, and data suggest higher rates of unintended pregnancy. Pregnant women with PHIV are younger and exposed to more antiretroviral therapy regimens compared with women with NPHIV. Although obstetric outcomes are similar between women with PHIV and NPHIV, there are concerns that infant morbidity may be increased in infants of women with PHIV.

Keywords: HIV; Perinatal HIV; Pregnancy; Pregnancy outcomes; Reproductive health.

Publication types

  • Review

MeSH terms

  • Anti-Retroviral Agents / therapeutic use
  • Disease Management*
  • Female
  • HIV Infections / drug therapy*
  • HIV Infections / psychology
  • Humans
  • Pregnancy
  • Pregnancy Complications, Infectious / drug therapy*
  • Pregnancy Complications, Infectious / psychology
  • Social Support
  • Treatment Outcome

Substances

  • Anti-Retroviral Agents